Across mammalian species in the evolutionary ladder, a-synuclein protein is highly conserved, even though synucleinopathy develops selectively in humans. Only the human a-synuclein mRNA contains an IRE-like sequence in its 5 0 -UTR, and, of note, generation of the human a-synuclein transcript requires RNA splicing out of an intron that precisely interrupts the canonical 5 0 -CAGUG-3 0 motif of the predicted 5 0 UTR stem loop. 10 Thus, it is possible that a unique role for a-synuclein in presynaptic redox and iron metabolism rapidly evolved in primates with selection for RNA splicing that favored a gain of post-transcriptional regulation for a-synuclein protein production.
If the novel stem-loop structure we describe in asynuclein mRNA functions to confer iron dependent post-transcriptional control, it would have implications for the central nervous system amyloidoses. It would immediately suggest a mechanism for induction of asynuclein by an age-related iron or redox pathophysiology upstream of neurodegeneration. Furthermore, it would provide an explanation for the well-characterized neuropathologic association of a-synuclein and the Alzheimer b-amyloid protein 3 since the Alzheimer bamyloid precursor protein mRNA also contains an IRE in its 5 0 -UTR. 8 If and how the IRE-like structure in asynuclein mRNA functions as a post-transcriptional regulator now awaits experimental clarification. Cocaine-amphetamine-regulated transcript (CART) gene was identified in 1995 in a search for mRNAs in the striatum acutely upregulated by psychostimulants. 1 CART is highest expressed in the hypothalamus and widely expressed in the central and peripheral nervous systems, as well as in endocrine cells.
AL
1,2 CART peptides have received much attention as mediators of stress, reward and reinforcement, appetite control, addiction and neuroendocrine regulation. 2 Recent studies link a mutation in the CART gene to obesity, type-II diabetes, anxiety and depression, and the mutation leads to CART deficiency or altered CART peptide levels, indicating a genetic cause for these human diseases or disorders. [3] [4] [5] [6] Although CART peptides have versatile functions, the mechanisms that mediate CART's effects are still poorly understood. Interestingly, intracerebroventricular injections of CART not only influenced food intake but also induced c-Fos expression in areas of the rat brain that are involved in feeding behavior. 7 Furthermore, CART knockout mice displayed increased body weight, and marked reduction of the expression of some important genes, such as pancreatic duodenal homeobox 1 (PDX-1) and glucose transporter-2 (GLUT-2) in pancreatic islets. 8 Thus, we tested the hypothesis that CART may have transcription function by a putative approach 9 in mammalian cells. First, we fused the conserved C-terminal region (residues 62-102) of CART 1 in-frame to the Gal4 DNA-binding domain (residues 1-147) of pM, a mammalian expression vector (BD Clontech, Palo Alto, CA, USA). The resulting plasmid pMCART was confirmed by DNA sequencing and the fusion protein was recognized by CART antibody (Phoenix, Inc., Belmont, CA, USA). We co-transfected pMCART or pM into HEK293 cells, a human embryonic kidney cell line, together with pTK-Gal-Luc, a Gal4-depending luciferase reporter vector that contains the firefly luciferase gene downstream of five consensus Gal4-binding sites and the minimal HSV-TK promoter, and with pcDNALacZ plasmid as an internal control for transfection efficiency. At 28 h after transfection, luciferase and b-galactosidase assays were performed on cell lysates using the commercial kits (Promega, Madison, WI, USA) according to the protocols. Luciferase activity of transgenes was normalized by b-galactosidase activity and is expressed as 'relative luciferase units' (RLU). The Gal4 domain alone (pM vector) caused a basic increase in luciferase activity; fusion of the CART region to the Gal4 domain (pMCART) significantly resulted in luciferase induction (B2.5-fold to pM, P < 0.05, Figure 1a ). To confirm this observation, a similar procedure was performed in rat primary cortical neuron culture system, with the exception of the pcDNALacZ in the transfection. Surprisingly, the results showed that pMCART more dramatically increase the luciferase activity compared with the empty vector pM (B14-fold, Figure 1b) . These data clearly indicate that the C-terminal domain in CART is a transactivator in mammalian cells.
The C-terminal for CART contains three disulfide bridges and is the bioactive part of the molecule affecting food intake. The CART structure has a fold equivalent to other functionally distinct small proteins, and consists mainly of turns and loops spanned by a compact framework of anti-parallel b-sheet common to cysteine knots. 10 Therefore, the CART peptide seems to form a new unique domain not found in any other peptides/proteins. Our finding for the first time that this domain has a trans-activating potential in mammalian cells provides an important mechanism of CART's actions. Although the CART receptor has not been identified yet, 2,11 our data showed that CART is more active in neurons than HEK cells, indicating one possibility that there are more CART receptors in neurons than HEK cells. Further studies to identify the receptor would greatly facilitate studies on the physiology, pathology and pharmacology of this potential neuroendocrine peptide.
In conclusion, the present communication is the first report of CART's direct transcriptional activity, and our data provide a basic mechanism for some of the regulatory actions of CART.
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Previously, several studies reported association between the synaptosomal-associated protein 25 kDa (SNAP-25) and attention deficit hyperactivity disorder (ADHD). Initially, Barr et al. 1 identified two single-nucleotide polymorphisms (SNPs) (MnlI, DdeI) located four bases apart in the 3 0 UTR of SNAP-25 and found significant overtransmission of the TC haplotype (P = 0.03). Since then, other researchers attempted to replicate this finding by investigating these two SNPs. Brophy et al.
2 found significant association for DdeI polymorphism but not for MnlI polymorphism. Kustanovich et al. 3 detected a trend for overtransmission of the TC haplotype (P = 0.08). Mill et al. 4 reported that the TT haplotype was 
